A Phase 1 Two-Part Study to Evaluate the Potential Drug Interactions Between ALXN2050 and Fluconazole, and Between ALXN2050 and Rifampin in Healthy Adult Participants
Latest Information Update: 06 Nov 2023
Price :
$35 *
At a glance
- Drugs Fluconazole (Primary) ; Rifampicin (Primary) ; Vemircopan (Primary)
- Indications Autoimmune disorders; Paroxysmal nocturnal haemoglobinuria
- Focus Pharmacokinetics
- Sponsors Alexion AstraZeneca Rare Disease
- 08 Dec 2021 Status changed from recruiting to completed.
- 30 Jun 2021 Status changed from not yet recruiting to recruiting.
- 25 Jun 2021 New trial record